Peter Slover
Net worth: 45 084 $ as of 2026-05-30
Net worth: 45 084 $ as of 2026-05-30
Mr. Peter T.
Slover, CPA, is a Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. Mr. Slover was previously employed as a Chief Financial & Accounting Officer by Sophiris Bio, Inc., a Vice President-Finance & Operations by Anadys Pharmaceuticals, Inc., and an Auditor by KPMG LLP.
He received his undergraduate degree from Shippensburg University of Pennsylvania.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-16 | 3,342 ( 0.01% ) | 45 084 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director of Finance/CFO | 2020-08-31 |
| Companies | Position | End |
|---|---|---|
| SOPHIRIS BIO | Director of Finance/CFO | 2020-04-30 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Director of Finance/CFO | - |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 2003-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Select your edition
All financial news and data tailored to specific country editions